AI models for the economic value of medicines
We train AI models that understand what a medicine is worth.
Pharmaccelerator trains domain models on health economics and outcomes research: HTA appraisals, economic evaluations, pricing and reimbursement decisions, and real-world outcomes. So that payers, manufacturers, investors and health systems can each assess the value of a medicine from their own perspective, with the evidence in view.
COST-EFFECTIVENESS PLANEPSA · ILLUSTRATIVE
P(cost-effective at threshold): 0%Mean ICER: — / QALY
Get in touch
Tell us which medicine, and whose value question you need to answer.
We will come back with a view on the evidence available, what a trained model could add, and what it would take to build one.